Malegra 100 (contains Sildenafil) is a prescription medicine in India, and its patient safety guidelines are ensured through multiple regulatory and clinical systems. 1. National drug regulator (main authority) In India, the primary authority is the: Central Drugs Standard Control Organisation (CDSCO) CDSCO is responsible for: Approving medicines before they are sold Setting safety standards and labeling rules Monitoring adverse drug reactions (side effects reports) Taking action if a medicine is unsafe or misused 2. Legal framework CDSCO works under: Drugs & Cosmetics Act, 1940 and Rules, 1945 This law ensures: Medicines meet safety, quality, and efficacy standards Manufacturers follow proper production and testing rules Prescription drugs (like Malegra 100) are not sold freely without control 3. State drug authorities Along with CDSCO: State drug control departments inspect pharmacies and manufacturers They enforce licensing and distribution safety 4. Pharmacovigilance (ongoing safety monitoring) India also runs: Pharmacovigilance Programme of India (PvPI) This system: Collects reports of side effects from hospitals and doctors Helps CDSCO update warnings or restrict unsafe batches if needed 5. Manufacturer responsibility Companies that produce Malegra 100 must: Follow Good Manufacturing Practices (GMP) Provide correct dosage, labeling, and warnings Report serious adverse effects Simple summary Safety of Malegra 100 is ensured by: CDSCO (main regulator) State drug authorities PvPI safety monitoring system Drug & Cosmetics Act laws Manufacturing quality rules If you want, I can also explain whether Malegra 100 is safe to use long-term or what risks are most important for you personally.